Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 3, 2015, Pages 582-590

  Wong, Grace Lai Hung ^a   Chan, Henry Lik Yuen ^a   Yu, Zhuo ^a   Wong, Catherine Ka Yan ^a   Leung, Calvin ^a   Ho, Patricia Po Lai ^a   Chan, Candace Yim ^a   Chung, Vivian Chi Yee ^a   Chan, Zhan Cham Yan ^a   Tse, Yee Kit ^a   Chim, Angel Mei Ling ^a   Lau, Tina Kit Ting ^a   Chan, Hoi Yun ^a   Tse, Chi Hang ^a   Wong, Vincent Wai Sun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cirrhosis; Clinical events; Death; Hepatocellular carcinoma; Liver stiffness measurement

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; BIOLOGICAL MARKER; TIE RECEPTOR;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DIGESTIVE TRACT PARAMETERS; ELASTOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEPATITIS B; HUI INDEX; HUMAN; LIVER FIBROSIS; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL; TRANSIENT ELASTOGRAPHY; AGE; AGED; BLOOD; COMPLICATION; DISEASE FREE SURVIVAL; LIVER CIRRHOSIS; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; COHORT STUDIES; DISEASE-FREE SURVIVAL; ELASTICITY IMAGING TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, TIE; SEVERITY OF ILLNESS INDEX; TRANSAMINASES;

EID: 84923223306     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12779     Document Type: Article

References (34)

1. Chan HL, Sung JJ. Hepatocellular carcinoma and hepatitis B virus. Semin. Liver Dis. 2006; 26: 153-161.
2. Chan HL, Tse CH, Mo F etal. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. J. Clin. Oncol. 2008; 26: 177-182.
3. Wong GL, Chan HL, Mak CW etal. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis. Hepatology 2013; 58: 1537-1547.
4. Wong VW, Chan SL, Mo F etal. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. J. Clin. Oncol. 2010; 28: 1660-1665.
5. Wong GL, Chan HL, Wong CK etal. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. J. Hepatol. 2014; 60: 339-345.
6. Wong GL, Wong VW, Choi PC, Chan AW, Chan HL. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B. Aliment. Pharmacol. Ther. 2010; 31: 1095-1103.
7. de Ledinghen V, Vergniol J, Barthe C etal. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus. Aliment. Pharmacol. Ther. 2013; 37: 979-988.
8. Hui AY, Chan HL, Wong VW etal. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am. J. Gastroenterol. 2005; 100: 616-623.
9. Wong GL, Wong VW, Choi PC etal. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J. Gastroenterol. Hepatol. 2009; 24: 1002-1007.
10. Wong GL, Wong VW, Choi PC etal. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography. Am. J. Gastroenterol. 2008; 103: 3071-3081.
11. Wong GL, Wong VW, Choi PC etal. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009; 58: 111-117.
12. Wong GL, Wong VW, Choi PC etal. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients. Clin. Gastroenterol. Hepatol. 2009; 7: 227-233.
13. Wong GL, Chan HL, Yu Z etal. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B-a prospective cohort study with paired transient elastography examinations. Aliment. Pharmacol. Ther. 2014; 39: 883-893.
14. Wong GL, Chan HL, Yu Z, Chan HY, Tse CH, Wong VW. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination. J. Gastroenterol. Hepatol. 2013; 28: 1842-1848.
15. Wong GL, Chan HL, Yu Z, Chan HY, Tse CH, Wong VW. Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: a prospective cohort study with paired transient elastography examination. J. Gastroenterol. Hepatol. 2013; 28: 1762-1769.
16. Chan HL, Chui AK, Lau WY etal. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. J. Med. Virol. 2002; 68: 182-187.
17. Chan HL, Wong GL, Tse CH, Chan HY, Wong VW. Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients. J. Infect. Dis. 2011; 204: 408-414.
18. Wong GL, Wong VW, Chan HY etal. Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years. Aliment. Pharmacol. Ther. 2012; 35: 1326-1335.
19. Wong GL. Transient elastography: kill two birds with one stone? World J. Hepatol. 2013; 5: 264-274.
20. Wong VW, Wong GL, Chan FK. Liver stiffness measurement: simplicity is prerequisite for reliability. Gastroenterology 2013; 144: 243-244.
21. Chan HL, Wong GL, Choi PC etal. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J. Viral Hepat. 2009; 16: 36-44.
22. Poynard T, Vergniol J, Ngo Y etal. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest) and transient elastography (FibroScan[R]). J. Hepatol. 2014; 60: 706-714.
23. Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology 2010; 51: 1445-1449.
24. Bruix J, Sherman M. American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
25. Wong GL. Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol. Rep. (Oxf). 2013; 1: 19-26.
26. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection. J. Hepatol. 2012; 57: 167-185.
27. Liaw YF, Kao JH, Piratvisuth T etal. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol. Int. 2012; 6: 531-561.
28. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662.
29. Castera L, Le Bail B, Roudot-Thoraval F etal. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J. Hepatol. 2009; 50: 59-68.
30. Vizzutti F, Arena U, Romanelli RG etal. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297.
31. Jung KS, Kim SU, Ahn SH etal. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011; 53: 885-894.
32. Wong GL, Chan HL, Choi PC etal. Association between anthropometric parameters and measurements of liver stiffness by transient elastography. Clin. Gastroenterol. Hepatol. 2013; 11: 295-302. e1-3.
33. Vergniol J, Boursier J, Coutzac C etal. The evolution of non-invasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology 2014; 60: 65-76.
34. Wong GL, Wong VW, Tan GM etal. Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. Liver Int. 2008; 28: 79-87.